UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Emicizumab for the treatment of acquired hemophilia A

Blood, 2021-01, Vol.137 (3), p.410-419

2021

Volltextzugriff (PDF)

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia

Blood, 2014-06, Vol.123 (25), p.3951-3962

2014

Volltextzugriff (PDF)

Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML

International journal of molecular sciences, 2019-02, Vol.20 (3), p.789

2019

Volltextzugriff (PDF)

Expression of CD25 on Leukemic Stem Cells in BCR-ABL1+ CML: Potential Diagnostic Value and Functional Implications

Experimental hematology, 2017-07, Vol.51, p.17-24

2017

Volltextzugriff (PDF)

Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis

Haematologica (Roma), 2020-02, Vol.105 (2), p.366

2020

Volltextzugriff (PDF)

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice

Haematologica (Roma), 2016-10, Vol.101 (10), p.1133

2016

Volltextzugriff (PDF)

Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience

Haematologica (Roma), 2011-02, Vol.96 (2), p.231-237

2011

Volltextzugriff (PDF)

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis

Haematologica (Roma), 2018-05, Vol.103 (5), p.799

2018

Volltextzugriff (PDF)

Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia

Haematologica (Roma), 2012-02, Vol.97 (2), p.246-250

2012

Volltextzugriff (PDF)

The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells

Journal of leukocyte biology, 2014-01, Vol.95 (1), p.95-104

2014

Volltextzugriff (PDF)

CD34+/CD38− stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin

Haematologica (Roma), 2012-02, Vol.97 (2), p.219-226

2012

Volltextzugriff (PDF)

How I treat patients with advanced systemic mastocytosis

Blood, 2010-12, Vol.116 (26), p.5812-5817

2010

Volltextzugriff (PDF)

Diagnosis and treatment of systemic mastocytosis: state of the art

British journal of haematology, 2003-09, Vol.122 (5), p.695-717

2003

Volltextzugriff (PDF)

Incidence of symptomatic Covid‐19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population

European journal of haematology, 2023-01, Vol.110 (1), p.67-76

2023

Volltextzugriff (PDF)

Rituximab for the treatment of acquired antibodies to factor VIII

Haematologica (Roma), 2007-01, Vol.92 (1), p.66-71

2007

Volltextzugriff (PDF)

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy

Blood, 2018-08, Vol.132 (7), p.694-706

2018

Volltextzugriff (PDF)

Influenza vaccination perception and coverage among patients with malignant disease

Vaccine, 2015-03, Vol.33 (14), p.1682-1687

2015

Volltextzugriff (PDF)

Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells

Best practice & research. Clinical haematology, 2010-09, Vol.23 (3), p.369-378

2010

Volltextzugriff (PDF)

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Blood, 2017-12, Vol.130 (23), p.2499-2503

2017

Volltextzugriff (PDF)

Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis

Thrombosis research, 2005, Vol.115 (1), p.59-64

2005

Volltextzugriff (PDF)

Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis

British journal of haematology, 2024-07

2024

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Aktive Filter

ThemaOncology

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(78)

Sprache

Englisch
(78)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(77)
Science & Technology
(77)
Humans
(68)
Middle Aged
(36)
Female
(35)
Male
(32)
Aged
(27)
Adult
(26)
Biological And Medical Sciences
(21)
Aged, 80 And Over
(19)
Medical Sciences
(19)
Prognosis
(19)
Hematologic And Hematopoietic Diseases
(16)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(12)
Young Adult
(11)
Adolescent
(10)
Mast Cells - Metabolism
(10)
Mutation
(10)
Immunology
(9)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Emicizumab for the treatment of acquired hemophilia A

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia

Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML

Expression of CD25 on Leukemic Stem Cells in BCR-ABL1+ CML: Potential Diagnostic Value and Functional Implications

Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice

Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis

Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia

Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis

The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells

CD34+/CD38− stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin

How I treat patients with advanced systemic mastocytosis

Diagnosis and treatment of systemic mastocytosis: state of the art

Incidence of symptomatic Covid‐19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Rituximab for the treatment of acquired antibodies to factor VIII

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy

Influenza vaccination perception and coverage among patients with malignant disease

Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Time-dependent changes in mortality and transformation risk in MDS

Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis

Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis

International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis

Aktive Filter

Suchergebnisse filtern